Many individuals who used Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, Trulicity, Victoza, or Zepbound have developed severe gastrointestinal or organ-related complications. This page explains the most common medical findings, diagnoses, and patterns that may qualify someone for a GLP-1 drug injury case review.
Eligibility can vary depending on symptoms, diagnosis, treatment, documentation, and timing. The information below reflects patterns seen in the strongest claim evaluations.
Eligibility Requirements for a GLP-1 lawsuit:
You may qualify for a GLP-1 injury claim if you:
1. Took a GLP-1 medication (Elli Lilly or Novo Nordisk drug / no compound drugs)
2. Must have a qualifying diagnosis that mandated medical care or hospitalization:
- Bowel obstruction or Ileus
- Intraoperative pulmonary aspiration
- Esophageal injury necessitating a surgery
- Necrotizing pancreatitis (NP)
- Gastroparesis
- Neuropathy with Gastroparesis (GP)
- Pancreatic cancer (No history of cancer diagnosis)
- Gallbladder removal (Cannot file ozempic lawsuit if started GLP-1 medication after warning label modification in March of 2022.)
- Stomach paralysis
- Persistent vomiting necessitating a visit to the hospital and/or a visit to the emergency department (ER) for IV fluids.
- Gastrointestinal GI injury needing surgical intervention
- Deep vein thrombosis (DVT) and similar side effects, including but not limited to death. (Only pertains well-controlled diabetics)
- Non-arteritic anterior ischemic optic neuropathy (NAION) or assorted vision problems or vision loss.
- Severe and ongoing side effects of nausea, constipation, diarrhea, vomiting or other gastrointestinal complications that necessitated emergency room trips, hospitalizations, multiple doctor appointments.
3. Victims with weight loss or bariatric surgeries are not eligible
4. Victims cannot have a radiation treatment in stomach abdominal area within 1 year before the commencement of side effects
5. Victims need to establish the date of the initial prescription,
6. No compound medication lawsuits.
Most qualified cases involve diagnostic confirmation, hospitalization, or persistent impairment. If symptoms became severe after a dose increase or prolonged use, this may further strengthen eligibility.
Injuries Most Commonly Considered Claim-Eligible
The strongest claim patterns involve one or more of these complications:
Gastroparesis (Stomach Paralysis)
A leading injury across case filings.
Qualifying indicators:
- stomach motility testing confirming delayed or impaired emptying
- chronic vomiting
- inability to tolerate normal eating
- extreme fullness after small meals
- long-term digestive impairment
➡️ Condition page: Gastroparesis
➡️ Legal page: Lawsuits Gastroparesis
Acute or Chronic Pancreatitis
Often requiring hospitalization.
Qualifying indicators:
- diagnosed pancreatitis
- lipase/amylase elevation
- imaging confirming inflammation
- repeated abdominal pain episodes
- recurrence after discharge
➡️ Pancreatitis Risk
➡️ Lawsuits Pancreatitis
Kidney Injury or Kidney Failure
Many kidney-related cases trace back to dehydration from vomiting or pancreatitis.
Indicators include:
- acute kidney injury (AKI)
- reduced eGFR
- elevated creatinine
- IV fluids or hospitalization
- dialysis in severe cases
Gallbladder Complications
Often triggered by rapid weight loss or bile disruption.
Qualifying examples:
- gallstones
- gallbladder inflammation
- bile duct obstruction
- gallbladder removal surgery (cholecystectomy)
➡️ Gallbladder Issues
➡️ Lawsuits Gallbladder Removal
Intestinal Obstruction or Severe Motility Disorder
Severe outcomes may involve:
- bowel shutdown
- inability to pass stool or gas
- abdominal distention
- hospitalization
- feeding tubes
➡️ Intestinal Obstruction
➡️ Lawsuits Intestinal Obstruction
Evidence That Strengthens Eligibility
Case reviewers typically look for objective medical documentation, including:
Diagnostic Confirmations
- gastric emptying scans
- CT or MRI imaging
- ER records
- GI motility studies
- renal panel abnormalities
Testing Results
- kidney filtration decline
- pancreatic enzyme elevation
- gallbladder ultrasound findings
- electrolyte imbalance from vomiting
Hospital Records
- admission notes
- discharge summaries
- test results
- surgical reports
Symptom Patterns Considered Red Flags
You may be considered eligible if you experienced:
- persistent nausea
- vomiting lasting weeks or months
- inability to maintain hydration
- rapid or unexplained weight loss
- repeated ER visits
- feeding tube placement
- ongoing abdominal pain
- permanent digestive changes
These symptoms are frequently referenced in current legal filings.
Duration of Use
Eligibility does not always depend on how long Ozempic or other GLP-1 drugs were taken.
However, many reported injury cases involve:
- several months of treatment
- dose escalation
- worsening symptoms after dose adjustments
Some cases appear sooner, especially in users with severe vomiting episodes.
Prior Health Conditions
Claims may still be eligible even if the patient had prior medical issues.
Core focus is generally on:
- whether symptoms began or worsened during GLP-1 use
- whether complications required medical intervention
- whether the injuries created lasting harm
Long-Term Impairment as a Key Factor
Conditions that are chronic, ongoing, or life-altering often produce the strongest eligibility outcomes.
Examples include:
- lifelong gastroparesis
- continuing kidney impairment
- recurrent pancreatitis episodes
- post-surgical digestive issues
- nutritional deterioration
- loss of normal eating function
When Symptoms Become Legally Significant
Reviewers often pay close attention if GLP-1 use results in:
- hospitalization
- surgery
- feeding or hydration support
- long-term medication
- specialist treatment
- medical disability or work leave
These factors are key signals that a case may have legal merit.
Timeline Factors Considered
Eligibility assessments often evaluate:
- onset of symptoms relative to starting medication
- whether symptoms escalated after dose increases
- whether complications appeared during active use
- persistence of symptoms after drug discontinuation
These relationships help determine causation patterns.
What If You’re Unsure About Your Diagnosis?
Many reviews begin simply with symptoms and medical history.
Even without formal diagnosis, you may qualify if symptoms are consistent with:
- gastroparesis
- pancreatitis
- bowel obstruction
- kidney injury
- gallbladder disease
➡️ Contact hub: Contact
If You Believe You May Qualify
Next steps generally include:
- identifying your GLP-1 drug
- noting when symptoms first appeared
- gathering records when possible
- documenting ER visits and tests
- requesting evaluation
➡️ Begin review: File a Claim
Additional Resources
Eligibility for GLP-1 drug injury claims is based on medical diagnosis, symptom patterns, treatment history, documentation, and long-term severity. The strongest cases involve confirmed organ injury, severe GI dysfunction, or permanent impairment following Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Saxenda, Victoza, or Zepbound use.
If you believe your condition may qualify, a review can help determine whether legal options are available.
➡️ Check eligibility: File a Claim